A multicentre, retrospective chart review study to describe the clinical profile of idiopathic pulmonary fibrosis (IPF) patients treated with nintedanib (OFEVĀ®) in real-world practice in Spain (BROAD) First published 01/06/2017 Last updated 31/03/2024 EU PAS number:EUPAS19384 Study Finalised